Promise of mineralocorticoid receptor blockade in asymptomatic left ventricular dysfunction

被引：2

作者：

Pitt, Bertram ^{[1
]}

机构：

[1] Univ Michigan, Sch Med, Ann Arbor, MI USA

来源：

HYPERTENSION | 2007年 / 50卷 / 03期

关键词：

D O I：

10.1161/HYPERTENSIONAHA.107.095356

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：461 / 462

页数：2

共 10 条

[1] Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction
Costello-Boerrigter, Lisa C.
Boerrigter, Guido
Harty, Gail J.
Cataliotti, Alessandro
Redfield, Margaret M.
Burnett, John C., Jr.
[J]. HYPERTENSION, 2007, 50 (03) : 481 - 488
[2] Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Gerling, IC
Sun, Y
Ahokas, RA
Wodi, LA
Bhattacharya, SK
Warrington, KJ
Postlethwaite, AE
Weber, KT
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (02): : H813 - H821
[3] Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction
Perrier, E
Kerfant, BG
Lalevee, N
Bideaux, P
Rossier, MF
Richard, S
Gómez, AM
Benitah, JP
[J]. CIRCULATION, 2004, 110 (07) : 776 - 783
[4] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B
Remme, W
Zannad, F
Neaton, J
Martinez, F
Roniker, B
Bittman, R
Hurley, S
Kleiman, J
Gatlin, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1309 - 1321
[5] Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy - The 4E-left ventricular hypertrophy study
Pitt, B
Reichek, N
Willenbrock, R
Zannad, F
Phillips, RA
Roniker, B
Kleiman, J
Krause, S
Burns, D
Williams, GH
[J]. CIRCULATION, 2003, 108 (15) : 1831 - 1838
[6] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Pitt, B
Zannad, F
Remme, WJ
Cody, R
Castaigne, A
Perez, A
Palensky, J
Wittes, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
[7] Effects of aldosterone on the vasculature
Schiffrin, EL
[J]. HYPERTENSION, 2006, 47 (03) : 312 - 318
[8] *SOLVD, 1992, NEW ENGL J MED, V327, P687
[9] Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure
Suzuki, G
Morita, H
Mishima, T
Sharov, VG
Todor, A
Tanhehco, EJ
Rudolph, AE
McMahon, EG
Goldstein, S
Sabbah, HN
[J]. CIRCULATION, 2002, 106 (23) : 2967 - 2972
[10] Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by β-adrenoreceptor activation
Veliotes, DGA
Woodiwiss, AJ
Deftereos, DAJ
Gray, D
Osadchii, O
Norton, GR
[J]. HYPERTENSION, 2005, 45 (05) : 914 - 920

← 1 →